Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03023904
Title Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST